Reproductive outcome after methotrexate treatment of tubal pregnancies.
OBJECTIVE
To evaluate reproductive outcome after ectopic pregnancy (EP) treated with methotrexate (MTX) and to assess the relative contribution of various risk factors to future fertility.


METHODS
Telephone follow-up interviews in a cohort of patients treated for EP.


METHODS
University hospital.


METHODS
A cohort of 158 patients treated with MTX for tubal pregnancies between April 1991 and March 1999.


METHODS
Assessment of fertility outcomes.


METHODS
Cumulative pregnancy rates for intrauterine and ectopic pregnancies.


RESULTS
Thirty-two patients (20.2%) were lost to follow-up. Of 126 patients, 93 (73.8%) sought to become pregnant, and of these 93 women, 76 (81.7%) did. Sixty-four pregnancies were spontaneous, and 12 resulted from in vitro fertilization (IVF). No pregnancies occurred in the group not trying to become pregnant. Of the 64 spontaneous pregnancies, 52 (81.2%) were intrauterine, with 12 (18.7%) resulting in miscarriages, and 12 (18.7%) were recurrent ectopic pregnancies. The cumulative intrauterine pregnancy rate was 57.5% after 1 year and 66.9% after 2 years. The cumulative ectopic pregnancy rate was 15.4% after 1 year and 23.7% after 2 years. After adjusting for factors associated with fertility with a Cox regression, only one factor was associated with poor reproductive performance: previous history of infertility.


CONCLUSIONS
Within 1 year of seeking to become pregnant, more than half the women previously treated medically for EP conceived and had ongoing pregnancies. Our analysis indicates that fertility depends more on the patients' previous medical history than on her treatment for EP.
Gervaise
Amélie
A
Service de Gynécologie-Obstétrique, Hôpital Antoine Béclère (AP-HP), 157 rue de la Porte-de-Trivaux, Clamart 92140, France.
Masson
Laurent
L
de Tayrac
Renaud
R
Frydman
René
R
Fernandez
Hervé
H
D000020:Abortifacient Agents, Nonsteroidal / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D005298:Fertility / Q000187:drug effects / Q000502:physiology*; D005307:Fertilization in Vitro; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D011247:Pregnancy; D011256:Pregnancy Outcome; D011274:Pregnancy, Tubal / Q000517:prevention & control*; D012098:Reproduction / Q000187:drug effects / Q000502:physiology*; D012189:Retrospective Studies; D016896:Treatment Outcome
D000020:Abortifacient Agents, Nonsteroidal; D008727:Methotrexate